Pharmaceutical industry – Page 13
-
Opinion
Blood offering
Antibodies in various forms could bridge the Covid-19 treatment gap until a vaccine is available
-
Opinion
Jumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
Business
Covid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
Business
Protein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
Business
Russian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
-
Business
Drop in plasma donations hits immunoglobulin supply
Lockdown and social distancing have discouraged donors, and the potential impact of convalescent plasma collection for Covid-19 treatment is unclear
-
Article
Exploring the advantages of single-crystal x-ray diffraction in pharma
Single-crystal x-ray diffraction (SCXRD) in drug development is evolving. Johnson Matthey outlines how technology advances and regulations are reshaping its role in pharma
-
Opinion
Facing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
Business
Russian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
Business
Encouraging signs from initial Covid-19 vaccine trials
Human trials deliver positive immune responses, while primate challenge studies suggest protection is possible
-
Article
Innovating in complex environments
The benefits of digital tools and automation with no programming required
-
Business
Deadly Indian incidents highlight relaxed regulations
Concern over human and environmental cost of reforms aimed at ease of doing business
-
-
Opinion
Looking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
-
Business
What are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
Article
Catalysts for collaboration
Demand for greener, more sustainable technologies in pharma, agro and fine chemicals sectors is growing – catalysis is at the heart of this transformation
-
Article
Catalysis and chemical bonds that make us stronger
Chemical and pharma industry is built on collaboration that draws on a wide range of expertise to develop innovative materials, compounds and components
-
Business
Scrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
Opinion
Dragons of immunology
Anti-inflammatories like dexamethasone are triumphs amid the pitfalls of the immune system
-
News
Covid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change